Stock Events

Stock Events

Search...

BB Biotech

€39.6

173

+€0.65+1.67% Thursday 15:30

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

2.13B

P/E Ratio

8.6

Dividend Yield

5.18%

Dividend

2.05

Upcoming

Dividend Payment

Dividend Payment

Dividends

5.18%Dividend Yield

10Y Growth

N/A

5Y Growth

-5.46%

3Y Growth

-14.37%

1Y Growth

-28.81%

Earnings

21OctExpected

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

-12.83

-1.86

9.1

20.07

Expected EPS

N/A

Actual EPS

-6.6352

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBZA.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

iShares Biotechnology

iShares Biotechnology ETF, competes by investing in biotech companies, similar to BB Biotech's investment strategy.

SPDR S&P Biotech ETF, competes as it also focuses on biotechnology investments, offering a similar market exposure.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund, a direct competitor through its biotech-focused investment portfolio.

ARK Genomic Revolution

ARK Genomic Revolution ETF, competes by investing in the genomic industry, overlapping with BB Biotech's investment interests.

VanEck Vectors Biotech ETF, offers exposure to biotech firms, directly competing with BB Biotech's investment focus.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF, competes through its focus on biotech and genomic revolution, akin to BB Biotech's strategy.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF, competes by investing in small- and mid-cap biotech companies, a market segment also targeted by BB Biotech.

Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares, competes as a leveraged ETF focusing on biotech, offering aggressive exposure similar to BB Biotech's sector focus.

Virtus LifeSci Biotech Products

Virtus LifeSci Biotech Products ETF, competes by investing in biotech companies with one or more drugs approved by the FDA, similar to some of BB Biotech's investments.

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares, competes by offering inverse exposure to the biotech sector, providing an alternative strategy to BB Biotech's investments.

About

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.

Show more...

CEO

Employees

10

Country

CH

ISIN

CH0038389992

WKN

000A0NFN3

Listings